Imatinib enhances functional outcome after spinal cord injury

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Abrams, Mathew B ^a   Nilsson, Ingrid ^a   Lewandowski, Sebastian A ^a   Kjell, Jacob ^a   Codeluppi, Simone ^a   Olson, Lars ^a   Eriksson, Ulf ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; IMATINIB; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEOCHONDROITIN SULFATE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTOSIS; BLADDER FUNCTION; BLOOD SPINAL CORD BARRIER; CONTROLLED STUDY; CONVALESCENCE; FEMALE; HINDLIMB; LOCOMOTION; NERVE FIBER; NEUROPROTECTION; NONHUMAN; PERMEABILITY BARRIER; PROTEIN EXPRESSION; RAT; SENSORIMOTOR INTEGRATION; SPINAL CORD; SPINAL CORD INJURY; TREATMENT DURATION; TREATMENT OUTCOME;

ANIMALS; ASTROCYTES; BLOOD-BRAIN BARRIER; CHONDROITIN SULFATE PROTEOGLYCANS; DISEASE MODELS, ANIMAL; FEMALE; INFLAMMATION; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; PIPERAZINES; PROTEIN KINASE INHIBITORS; PYRIMIDINES; RATS; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; RECOVERY OF FUNCTION; SPINAL CORD INJURIES; TREATMENT OUTCOME;

EID: 84862528742     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038760     Document Type: Article

References (49)

1. Tator CH, Fehlings MG, (1991) Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg 75: 15-26.
2. Norenberg MD, Smith J, Marcillo A, (2004) The pathology of human spinal cord injury: defining the problems. J Neurotrauma 21: 429-440.
3. Nakajima K, Kohsaka S, (2001) Microglia: activation and their significance in the central nervous system. J Biochem 130: 169-175.
4. Neumann H, Wekerle H, (1998) Neuronal control of the immune response in the central nervous system: linking brain immunity to neurodegeneration. J Neuropathol Exp Neurol 57: 1-9.
5. Paniagua RT, Sharpe O, Ho PP, Chan SM, Chang A, et al. (2006) Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis. J Clin Invest 116: 2633-2642.
6. Fabian MA, Biggs WH 3rd, Treiber DK, Atteridge CE, Azimioara MD, et al (2005) A small molecule-kinase interaction map for clinical kinase inhibitors. Nat Biotechnol 23: 329-336.
7. Leder C, Ortler S, Seggewiss R, Einsele H, Wiendl H, (2007) Modulation of T-effector function by imatinib at the level of cytokine secretion. Exp Hematol 35: 1266-1271.
8. Su EJ, Fredriksson L, Geyer M, Folestad E, Cale J, et al. (2008) Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat Med 14: 731-737.
9. Boucher P, Gotthardt M, Li WP, Anderson RG, Herz J, (2003) LRP: role in vascular wall integrity and protection from atherosclerosis. Science 300: 329-332.
10. Lassila M, Allen TJ, Cao Z, Thallas V, Jandeleit-Dahm KA, et al. (2004) Imatinib attenuates diabetes-associated atherosclerosis. Arterioscler Thromb Vasc Biol 24: 935-942.
11. Ma Q, Huang B, Khatibi N, Rolland W 2nd, Suzuki H, et al (2011) PDGFR-alpha inhibition preserves blood-brain barrier after intracerebral hemorrhage. Ann Neurol 70: 920-931.
12. Miyanji F, Furlan JC, Aarabi B, Arnold PM, Fehlings MG, (2007) Acute cervical traumatic spinal cord injury: MR imaging findings correlated with neurologic outcome-prospective study with 100 consecutive patients. Radiology 243: 820-827.
13. Lammertse D, Tuszynski MH, Steeves JD, Curt A, Fawcett JW, et al. (2007) Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: clinical trial design. Spinal Cord 45: 232-242.
14. Popovich PG, Wei P, Stokes BT, (1997) Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J Comp Neurol 377: 443-464.
15. Hausmann ON, (2003) Post-traumatic inflammation following spinal cord injury. Spinal Cord 41: 369-378.
16. Hulsebosch CE, (2002) Recent advances in pathophysiology and treatment of spinal cord injury. Adv Physiol Educ 26: 238-255.
17. Kwon BK, Tetzlaff W, Grauer JN, Beiner J, Vaccaro AR, (2004) Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J 4: 451-464.
18. Flanders AE, Spettell CM, Tartaglino LM, Friedman DP, Herbison GJ, (1996) Forecasting motor recovery after cervical spinal cord injury: value of MR imaging. Radiology 201: 649-655.
19. Schaefer DM, Flanders AE, Osterholm JL, Northrup BE, (1992) Prognostic significance of magnetic resonance imaging in the acute phase of cervical spine injury. J Neurosurg 76: 218-223.
20. Tang Z, Arjunan P, Lee C, Li Y, Kumar A, et al. (2010) Survival effect of PDGF-CC rescues neurons from apoptosis in both brain and retina by regulating GSK3beta phosphorylation. J Exp Med 207: 867-880.
21. Anderson KD, (2004) Targeting recovery: priorities of the spinal cord-injured population. J Neurotrauma 21: 1371-1383.
22. Hugenholtz H, (2003) Methylprednisolone for acute spinal cord injury: not a standard of care. CMAJ 168: 1145-1146.
23. Basso DM, Beattie MS, Bresnahan JC, (1996) Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol 139: 244-256.
24. Garcia-Alias G, Barkhuysen S, Buckle M, Fawcett JW, (2009) Chondroitinase ABC treatment opens a window of opportunity for task-specific rehabilitation. Nat Neurosci 12: 1145-1151.
25. Bradbury EJ, Moon LD, Popat RJ, King VR, Bennett GS, et al. (2002) Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416: 636-640.
26. Silver J, Miller JH, (2004) Regeneration beyond the glial scar. Nat Rev Neurosci 5: 146-156.
27. Sellers DL, Maris DO, Horner PJ, (2009) Postinjury niches induce temporal shifts in progenitor fates to direct lesion repair after spinal cord injury. J Neurosci 29: 6722-6733.
28. Carroll WM, Jennings AR, Ironside LJ, (1998) Identification of the adult resting progenitor cell by autoradiographic tracking of oligodendrocyte precursors in experimental CNS demyelination. Brain 121 (Pt 2): 293-302.
29. Keirstead HS, Levine JM, Blakemore WF, (1998) Response of the oligodendrocyte progenitor cell population (defined by NG2 labelling) to demyelination of the adult spinal cord. Glia 22: 161-170.
30. McTigue DM, Wei P, Stokes BT, (2001) Proliferation of NG2-positive cells and altered oligodendrocyte numbers in the contused rat spinal cord. J Neurosci 21: 3392-3400.
31. Moransard M, Dann A, Staszewski O, Fontana A, Prinz M, et al. (2011) NG2 expressed by macrophages and oligodendrocyte precursor cells is dispensable in experimental autoimmune encephalomyelitis. Brain 134: 1315-1330.
32. Matsumoto H, Kumon Y, Watanabe H, Ohnishi T, Shudou M, et al. (2008) Accumulation of macrophage-like cells expressing NG2 proteoglycan and Iba1 in ischemic core of rat brain after transient middle cerebral artery occlusion. J Cereb Blood Flow Metab 28: 149-163.
33. Dewar AL, Cambareri AC, Zannettino AC, Miller BL, Doherty KV, et al. (2005) Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib. Blood 105: 3127-3132.
34. Pixley FJ, Stanley ER, (2004) CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol 14: 628-638.
35. Potas JR, Zheng Y, Moussa C, Venn M, Gorrie CA, et al. (2006) Augmented locomotor recovery after spinal cord injury in the athymic nude rat. J Neurotrauma 23: 660-673.
36. Popovich PG, Guan Z, Wei P, Huitinga I, van Rooijen N, et al. (1999) Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp Neurol 158: 351-365.
37. Bao F, Omana V, Brown A, Weaver LC, (2012) The Systemic Inflammatory Response after Spinal Cord Injury in the Rat is Decreased by alpha4beta1 Integrin Blockade. J Neurotrauma.
38. Campbell SJ, Perry VH, Pitossi FJ, Butchart AG, Chertoff M, et al. (2005) Central nervous system injury triggers hepatic CC and CXC chemokine expression that is associated with leukocyte mobilization and recruitment to both the central nervous system and the liver. Am J Pathol 166: 1487-1497.
39. Wilcockson DC, Campbell SJ, Anthony DC, Perry VH, (2002) The systemic and local acute phase response following acute brain injury. J Cereb Blood Flow Metab 22: 318-326.
40. Rivers LE, Young KM, Rizzi M, Jamen F, Psachoulia K, et al. (2008) PDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice. Nat Neurosci 11: 1392-1401.
41. Virgintino D, Girolamo F, Errede M, Capobianco C, Robertson D, et al. (2007) An intimate interplay between precocious, migrating pericytes and endothelial cells governs human fetal brain angiogenesis. Angiogenesis 10: 35-45.
42. Morelli PI, Martinsson S, Ostergren-Lunden G, Friden V, Moses J, et al. (2006) IFNgamma regulates PDGF-receptor alpha expression in macrophages, THP-1 cells, and arterial smooth muscle cells. Atherosclerosis 184: 39-47.
43. Dore-Duffy P, Owen C, Balabanov R, Murphy S, Beaumont T, et al. (2000) Pericyte migration from the vascular wall in response to traumatic brain injury. Microvasc Res 60: 55-69.
44. Barbas D, Campbell A, Castellucci VF, DesGroseillers L, (2005) Comparative localization of two serotonin receptors and sensorin in the central nervous system of Aplysia californica. J Comp Neurol 490: 295-304.
45. Merrill JE, Zimmerman RP, (1991) Natural and induced cytotoxicity of oligodendrocytes by microglia is inhibitable by TGF beta. Glia 4: 327-331.
46. Fleming JC, Norenberg MD, Ramsay DA, Dekaban GA, Marcillo AE, et al. (2006) The cellular inflammatory response in human spinal cords after injury. Brain 129: 3249-3269.
47. Argaw AT, Gurfein BT, Zhang Y, Zameer A, John GR, (2009) VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown. Proc Natl Acad Sci U S A 106: 1977-1982.
48. Koto T, Takubo K, Ishida S, Shinoda H, Inoue M, et al. (2007) Hypoxia disrupts the barrier function of neural blood vessels through changes in the expression of claudin-5 in endothelial cells. Am J Pathol 170: 1389-1397.
49. Gundersen HJ, (1986) Stereology of arbitrary particles. A review of unbiased number and size estimators and the presentation of some new ones, in memory of William R. Thompson. J Microsc 143: 3-45.